When compared to daily oral treatment, British pharmaceutical company GSK said on Wednesday that its long-acting injectable HIV medicine has shown promise in suppressing the viral load of infected individuals,…

The FDA has approved a treatment protocol for a particular type of lung cancer that combines chemotherapy and AstraZeneca’s popular cancer medicine Tagrisso, according to an announcement by the firm…

On Friday, global pharmaceutical giant Sanofi announced it had received an approval for its new treatment for sleeping sickness, called rhodesiense, from the European Medicines Agency (EMA). In the announcement,…

On Sunday, the Financial Times reported that AstraZenica, the Anglo-Swedish drugmaker, has linked up with US artificial intelligence (AI) biologics firm Absci, in a deal worth $247 million, which will…

On Wednesday, Bayer announced that it was exploring splitting off either the diversified group’s Consumer Health or Crop Science divisions, however it ruled out performing a three-way split. In a…

On Tuesday, the US Food and Drug Administration (FDA) announced that it has accepted AstraZeneca’s application seeking approval to sell a new nasal flu vaccine which will allow patients and…

On Monday, Roche announced it would be buying Televant, a biotechnology firm which has developed a new treatment for inflammatory bowel diseases. The firm will be sold for an initial…

Novo Nordisk, the Danish Pharmaceutical giant, has supplanted French luxury conglomerate LVMH, the biggest retailer of luxury goods in the world, and owner of brands such as Louis Vuitton and…

According to a new report in the Wall Street Journal on Friday, Rite Aid Corp (RAD.N) in making preparations to file for bankruptcy in the coming weeks, as the company…

Teva Pharmaceuticals, the generic drug maker, has agreed to pay $225 million over allegations of price-fixing related to its sales of a popular cholesterol-lowering drug. Under the agreement Monday with…